Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis

Castigliano Bhamidipati, Jay D. Pal, Thomas K. Jones, James M. McCabe, Mark Reisman, Jason W. Smith, Claudius Mahr, Nahush A. Mokadam

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

The duration of support in patients with HeartMate II implantation as a bridge to transplant or as destination therapy is rising. As clinical experience continues to grow, physiologic changes contributing to pump malfunction are becoming apparent. Once malfunction is noted with increased power spikes, rises in lactate dehydrogenase and low-flow alarms, thrombosis of the pump is at risk. We describe outflow graft compression and offer an expeditious and definitive management strategy. Our novel management stenting strategy for outflow graft compression will continue to evolve as experience is gained.

Original languageEnglish (US)
Pages (from-to)e101-e104
JournalAnnals of Thoracic Surgery
Volume103
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis'. Together they form a unique fingerprint.

  • Cite this

    Bhamidipati, C., Pal, J. D., Jones, T. K., McCabe, J. M., Reisman, M., Smith, J. W., Mahr, C., & Mokadam, N. A. (2017). Outflow Graft Obstruction Treated With Transcatheter Management: A Novel Therapy for a New Diagnosis. Annals of Thoracic Surgery, 103(1), e101-e104. https://doi.org/10.1016/j.athoracsur.2016.07.031